Key Insights

Highlights

Success Rate

95% trial completion (above average)

Research Maturity

80 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.5%

4 terminated out of 161 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

27%

43 trials in Phase 3/4

Results Transparency

5%

4 of 80 completed with results

Key Signals

4 with results95% success

Data Visualizations

Phase Distribution

133Total
Not Applicable (71)
Early P 1 (1)
P 1 (7)
P 2 (11)
P 3 (16)
P 4 (27)

Trial Status

Completed80
Recruiting29
Unknown23
Not Yet Recruiting10
Withdrawn5
Active Not Recruiting5

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 80 completed trials

Clinical Trials (161)

Showing 20 of 20 trials
NCT06732453Not ApplicableCompletedPrimary

Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)

NCT04526119Phase 3CompletedPrimary

A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

NCT07715760Not ApplicableNot Yet RecruitingPrimary

Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome

NCT05653310Phase 2Enrolling By InvitationPrimary

Tradipitant for Functional Dyspepsia

NCT06360900Not ApplicableRecruitingPrimary

Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia

NCT07694778RecruitingPrimary

Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh : A Cross Sectional Study

NCT07686679Phase 4Not Yet RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

NCT01822470Enrolling By InvitationPrimary

Small Intestinal Bacterial Overgrowth: A Prospective Registry

NCT06657001Enrolling By Invitation

Enabling Microbiomics- Driven Personalized Nutrition

NCT06854120Recruiting

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

NCT05513040CompletedPrimary

Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment

NCT07584473Not ApplicableRecruiting

NCWS or IBS/FD in Relatives of CD Patients

NCT07577089Not ApplicableNot Yet RecruitingPrimary

Cognitive Behavioral Therapy for Functional Dyspepsia (Epigastric Pain Syndrome and Postprandial Distress Syndrome Subtypes)

NCT07000227Not ApplicableRecruiting

Mechanism of FODMAP Restriction on FGID Patients

NCT07008235Phase 2RecruitingPrimary

Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia

NCT04482478Not ApplicableRecruitingPrimary

Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia

NCT05812339Enrolling By Invitation

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

NCT03176927Early Phase 1Completed

Biomagnetic Characterization of Gastric Dysrhythmias III

NCT07539051Not Yet RecruitingPrimary

Psychoemotional Status and Functional Gastrointestinal Disorders

NCT06748274Not ApplicableCompleted

The Brain-Heart-Gut Connection

Scroll to load more

Research Network

Activity Timeline